We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Solvay Doubles Specialty Fluorinated Derivatives Production Capacity in France
News

Solvay Doubles Specialty Fluorinated Derivatives Production Capacity in France

Solvay Doubles Specialty Fluorinated Derivatives Production Capacity in France
News

Solvay Doubles Specialty Fluorinated Derivatives Production Capacity in France

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Solvay Doubles Specialty Fluorinated Derivatives Production Capacity in France"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Solvay announced today it is doubling the production capacity for specialty fluorinated aliphatic derivatives at its plant in Salindres, France, to keep up with the growing demand in strategic markets, such as energy storage, electronics and pharmaceuticals. The Group is investing over EUR 10 million in the plant to double the capacity of the fluorinated aliphatic derivatives production line. The project’s first stage is currently underway and the first additional volumes will be available this month. 

The Group decided to double production capacity for triflic acid and triflic anhydride (TA, TAA), as well as for Lithium bis(trifluoromethanesulfonyl)imide (LiTFSI), to meet the rapidly expanding requirements of electronic applications (such as antistatic applications for flat screens, ionic liquids and liquid crystals), the battery market (for automobiles and computers) and the pharmaceuticals market. 

“This capacity expansion is strengthening the role of our Salindres plant as a major production site for innovative fluorinated aliphatic derivatives,” commented Alessandro Chiovato, General Manager of the Crop Protection, Health & Electronics business at Solvay's Global Business Unit Rhodia Aroma Performance. “It will bring us in a better position to support the growth of our customers in all regions,” he added.

Advertisement